Research graph
References from Antidiabetic drug administration prevents bone mineral density loss: Evidence from a two-sample Mendelian randomization study. Local targets link to admitted publications; unresolved targets remain external evidence.
Osteoporosis in elderly: prevention and treatment
10.1016/s0749-0690(02)00022-8 · 2002 · External reference
Pathophysiology of osteoporosis: new mechanistic insights
10.1016/j.ecl.2012.04.006 · 2012 · External reference
Osteoporosis and fracture risk in older people
10.7861/clinmedicine.14-2-187 · 2014 · External reference
Risk factors for osteoporosis and associated fractures (1989)
External reference
Management of diabetes in the elderly
10.1016/j.mcna.2014.11.008 · 2015 · External reference
Diagnosis and classification of diabetes mellitus
10.2337/dc13-s067 · 2013 · External reference
Efficacy of Osteoporosis Therapies in Diabetic Patients
10.1007/s00223-016-0177-8 · 2017 · External reference
An atlas of genetic influences on osteoporosis in humans and mice
10.1038/s41588-018-0302-x · 2019 · External reference
Osteoporosis-associated fracture and diabetes
10.1016/j.ecl.2013.09.004 · 2014 · External reference
Diabetes Mellitus and Osteoporosis Correlation
10.2174/1573399816666200324152517 · 2020 · External reference
Development and validation of a risk prediction model for osteoporosis in elderly patients with type 2 diabetes mellitus: a retrospective and multicenter study
10.1186/s12877-023-04306-1 · 2023 · External reference
Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study
10.1016/j.diabres.2023.110980 · 2023 · External reference
Mechanisms of diabetes mellitus-induced bone fragility
10.1038/nrendo.2016.153 · 2017 · External reference
Potential causal association between aspirin use and erectile dysfunction in European population: a Mendelian randomization study
10.3389/fendo.2023.1329847 · 2023 · External reference
Association between gut microbiota and glioblastoma: a Mendelian randomization study
10.3389/fgene.2023.1308263 · 2023 · External reference
Association Between Neurodegenerative Diseases and an Increased Risk of Epilepsy Based on Single Nucleotide Polymorphisms: A Mendelian Randomization Study
2024 · External reference
Impact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation study
10.3389/fmicb.2023.1320279 · 2023 · External reference
1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study
10.1371/journal.pmed.1004327 · 2024 · External reference
Nutritional Aspects to Cardiovascular Diseases and Type 2 Diabetes Mellitus
2024 · External reference
Diabetes and the Microvasculature of the Bone and Marrow
2024 · External reference
Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study
10.1016/j.bone.2023.116997 · 2024 · External reference
An update on therapies for the treatment of diabetes-induced osteoporosis
10.1080/14712598.2019.1618266 · 2019 · External reference
Osteoporosis and major fragility fractures (MOF) in sarcoidosis patients: association with disease severity
2023 · External reference
Causal association of epigenetic aging and osteoporosis: a bidirectional Mendelian randomization study
10.1186/s12920-023-01708-3 · 2023 · External reference
Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis
10.3389/fendo.2021.735824 · 2021 · External reference
Long-term effects of lifestyle and metformin interventions in DPP on bone density
10.1007/s00198-021-05989-1 · 2021 · External reference
Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus.
10.12998/wjcc.v8.i18.4010 · 2020 · External reference
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model
10.1590/1678-7757-2018-0211 · 2019 · External reference
Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
2022 · External reference
Metformin enhances osteogenic differentiation of stem cells from human exfoliated deciduous teeth through AMPK pathway
10.1002/term.3142 · 2020 · External reference
Metformin promotes differentiation of human bone marrow derived mesenchymal stem cells into osteoblast via GSK3β inhibition
2018 · External reference
Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation
10.7754/clin.lab.2013.130531 · 2014 · External reference
Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
10.1186/s13098-017-0232-2 · 2017 · External reference
